The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder
- Authors
- Bae, Seung Min; Hong, Ji Yeon
- Issue Date
- May-2018
- Publisher
- KOREAN COLL NEUROPSYCHOPHARMACOLOGY
- Keywords
- Autism spectrum disorder; Wnt; Beta-catenin; Chromodomain helicase DNA binding protein 8; Neuronal development
- Citation
- CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, v.16, no.2, pp.129 - 135
- Journal Title
- CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
- Volume
- 16
- Number
- 2
- Start Page
- 129
- End Page
- 135
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3805
- DOI
- 10.9758/cpn.2018.16.2.129
- ISSN
- 1738-1088
- Abstract
- Autism spectrum disorder (ASD) is a series of neurodevelopmental disorder with a large genetic component. However, the pathogenic genes and molecular mechanisms of ASD have not been clearly defined. Recent technological advancements, such as next-generation sequencing, have led to the identification of certain loci that is responsible for the pathophysiology of ASD. Three functional pathways, such as chromatin remodeling, Wnt signaling and mitochondrial dysfunction are potentially involved in ASD. In this review, we will focus on recent studies of the involvement of Wnt signaling pathway components in ASD pathophysiology and related drugs used in ASD treatment.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3805)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.